• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Nutriband Inc (NQ: NTRB )

    7.590 +0.350 (+4.83%)
    Streaming Delayed Price Updated: 10:33 AM EDT, Jul 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 16,789
    Open 7.350
    Bid (Size) 7.300 (3)
    Ask (Size) 7.590 (2)
    Prev. Close 7.240
    Today's Range 7.350 - 7.750
    52wk Range 1.530 - 7.400
    Shares Outstanding 6,356,270
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Execs to Participate in July 25 Investor Webinar
    Via Investor Brand Network
    Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25
    Via ACCESSWIRE

    Performance

    YTD
    +227.99%
    +227.99%
    1 Month
    +45.96%
    +45.96%
    3 Month
    +114.41%
    +114.41%
    6 Month
    +189.69%
    +189.69%
    1 Year
    +92.15%
    +92.15%

    More News

    Read More
    BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Obtains Notice of Allowance for Key Trademark Identified as ‘Integral’ to Platform Technology
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology
    Via ACCESSWIRE
    NTRB Stock Earnings: Nutriband Reported Results for Q1 2024
    Via InvestorPlace
    Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors
    Via ACCESSWIRE
    NTRB Stock Earnings: Nutriband Reported Results for Q4 2023
    Via InvestorPlace
    BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Shares Update on Its AVERSA(TM) Fentanyl Product Development Program
    Via Investor Brand Network
    Exposures Product Safety
    Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl
    Via ACCESSWIRE
    BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Releases Q1 2024 Quarterly Report
    Via Investor Brand Network
    Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year
    Via ACCESSWIRE
    BioMedNewsBreaks — Why Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Schedules Live Investor Webinar, Q&A Session
    Via Investor Brand Network
    BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Names Seasoned Business Leader to Board of Directors
    Via Investor Brand Network
    Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Featured in Upcoming RedChip Small, Big Money(TM) Show
    Via Investor Brand Network
    Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESSWIRE
    Fentanyl Scourge: Nutriband Inc.’s (NASDAQ: NTRB) New Transdermal Patch with Abuse-Deterrent Tech Funded to Seek FDA Approval
    Via Investor Brand Network
    Exposures Product Safety
    BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Engages IBN for Corporate Communications Expertise
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Closes $8.4M Private Placement
    Via Investor Brand Network
    Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission
    Via ACCESSWIRE
    BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Enters Exclusive Supplier Agreement with Major Sports Brand Licensee
    Via Investor Brand Network
    Topics Supply Chain
    Exposures Supply Chain
    Nutriband Inc. (NASDAQ: NTRB) Advances Abuse Deterrent Tech Addressing Fentanyl Epidemic
    Via Investor Brand Network
    Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group
    Via ACCESSWIRE
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.